Standout Papers

Role of oxidized low density lipoprotein in atherogenesis. 1987 2026 2000 2013 2.2k
  1. Role of oxidized low density lipoprotein in atherogenesis. (1991)
    Joseph L. Witztum, Daniel Steinberg Journal of Clinical Investigation
  2. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. (1989)
    Seppo Ylä‐Herttuala, Wulf Palinski et al. Journal of Clinical Investigation
  3. Low Density Lipoprotein Oxidation and Its Pathobiological Significance (1997)
    Daniel Steinberg Journal of Biological Chemistry
  4. Low density lipoprotein undergoes oxidative modification in vivo. (1989)
    Wulf Palinski, Michael E. Rosenfeld et al. Proceedings of the National Academy of Sciences
  5. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. (1987)
    T E Carew, Dawn C. Schwenke et al. Proceedings of the National Academy of Sciences
  6. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins. (1981)
    Tore Henriksen, Eileen M. Mahoney et al. Proceedings of the National Academy of Sciences
  7. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. (1991)
    Seppo Ylä‐Herttuala, Beth Lipton et al. Proceedings of the National Academy of Sciences
  8. Lewis A. Conner Memorial Lecture (1997)
    Daniel Steinberg Circulation
  9. The oxidative modification hypothesis of atherogenesis: an overview (2000)
    Guy Chisolm, Daniel Steinberg Free Radical Biology and Medicine
  10. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. (1988)
    Mark T. Quinn, S Parthasarathy et al. Proceedings of the National Academy of Sciences
  11. Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime (2002)
    Daniel Steinberg Nature Medicine
  12. Probucol inhibits oxidative modification of low density lipoprotein. (1986)
    S Parthasarathy, Stephen G. Young et al. Journal of Clinical Investigation
  13. Dissociation of tissue uptake of cholesterol ester from that of apoprotein A-I of rat plasma high density lipoprotein: selective delivery of cholesterol ester to liver, adrenal, and gonad. (1983)
    Christopher K. Glass, R C Pittman et al. Proceedings of the National Academy of Sciences
  14. STUDIES ON THE SYNTHESIS AND SECRETION OF SERUM LIPOPROTEINS BY RAT LIVER SLICES (1960)
    Charles M. Radding, Daniel Steinberg Journal of Clinical Investigation

Immediate Impact

89 by Nobel laureates 41 from Science/Nature 190 standout
Sub-graph 1 of 13

Citing Papers

Regulation of Ferroptotic Cancer Cell Death by GPX4
2014 Standout
Leukocyte Behavior in Atherosclerosis, Myocardial Infarction, and Heart Failure
2013 StandoutScience
9 intermediate papers

Works of Daniel Steinberg being referenced

Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.
1994
Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes.
1993
and 14 more

Author Peers

Author Last Decade Papers Cites
Daniel Steinberg 13832 5297 11133 10639 437 42.2k
Joseph L. Witztum 21273 10105 18095 14661 455 70.4k
Alan M. Fogelman 10577 3379 8409 4365 263 31.0k
Jay W. Heinecke 5593 2307 8283 4446 265 28.7k
Garret A. FitzGerald 5361 9752 11251 4116 482 49.0k
David G. Harrison 7224 20168 13916 3156 396 59.3k
Alan Chait 7315 4739 5725 3139 270 24.3k
Stanley L. Hazen 7286 6232 25563 2418 477 53.6k
John F. Keaney 4058 8609 6191 4382 250 30.4k
Roland Stocker 3152 1495 13599 7533 314 31.4k
Kathy K. Griendling 3998 12775 16883 2477 228 45.3k

All Works

Loading papers...

Rankless by CCL
2026